Reduced inotropic support after aprotinin therapy during pediatric cardiac operations.

PubWeight™: 0.88‹?›

🔗 View Article (PMID 10086544)

Published in Ann Thorac Surg on January 01, 1999

Authors

C F Wippermann1, F X Schmid, B Eberle, R G Huth, C Kampmann, D Schranz, H Oelert

Author Affiliations

1: Department of Pediatric Cardiology, University of Mainz, Germany. C.-F.Wippermann@t-online.de

Articles by these authors

Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature (1989) 8.48

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest (2004) 4.54

Two exposed amino acid residues confer thermostability on a cold shock protein. Nat Struct Biol (2000) 3.27

GroE facilitates refolding of citrate synthase by suppressing aggregation. Biochemistry (1991) 2.92

Effect of medical and surgical therapy on aortic dissection evaluated by transesophageal echocardiography. Implications for prognosis and therapy. The European Cooperative Study Group on Echocardiography. Circulation (1993) 2.74

The mechanism of protein folding. Implications of in vitro refolding models for de novo protein folding and translocation in the cell. Biochemistry (1990) 2.68

The GroE chaperonin machine is a major modulator of the CIRCE heat shock regulon of Bacillus subtilis. EMBO J (1997) 2.50

Extremely rapid protein folding in the absence of intermediates. Nat Struct Biol (1995) 2.43

Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis (2005) 2.40

Catalysis of protein folding by prolyl isomerase. Nature (1987) 2.21

The SurA periplasmic PPIase lacking its parvulin domains functions in vivo and has chaperone activity. EMBO J (2001) 2.12

Respiratory mechanics, gastric insufflation pressure, and air leakage of the laryngeal mask airway. Anesth Analg (1997) 2.02

Surgical treatment of pulmonary artery sarcoma. J Thorac Cardiovasc Surg (2001) 1.91

Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach. A prospective study. Eur Heart J (1988) 1.90

Normal values of M mode echocardiographic measurements of more than 2000 healthy infants and children in central Europe. Heart (2000) 1.83

The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet (2004) 1.79

A ribosome-associated peptidyl-prolyl cis/trans isomerase identified as the trigger factor. EMBO J (1995) 1.79

Acid catalysis of the formation of the slow-folding species of RNase A: evidence that the reaction is proline isomerization. Proc Natl Acad Sci U S A (1978) 1.78

Conservation of rapid two-state folding in mesophilic, thermophilic and hyperthermophilic cold shock proteins. Nat Struct Biol (1998) 1.78

Multidisciplinary management of Hunter syndrome. Pediatrics (2009) 1.76

Isolation and sequence of an FK506-binding protein from N. crassa which catalyses protein folding. Nature (1990) 1.74

Impending paradoxical embolism from atrial thrombus: correct diagnosis by transesophageal echocardiography and prevention by surgery. J Am Coll Cardiol (1985) 1.70

Diffusion control in an elementary protein folding reaction. Proc Natl Acad Sci U S A (1997) 1.69

Natural history of Fabry disease in females in the Fabry Outcome Survey. J Med Genet (2005) 1.67

Role of proline isomerization in folding of ribonuclease A at low temperatures. Proc Natl Acad Sci U S A (1979) 1.65

Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis (2001) 1.56

Catalysis of protein folding by cyclophilins from different species. J Biol Chem (1991) 1.56

Detection of an early intermediate in the folding of ribonuclease A by protection of amide protons against exchange. J Mol Biol (1979) 1.55

Cooperation of enzymatic and chaperone functions of trigger factor in the catalysis of protein folding. EMBO J (1997) 1.49

Thermodynamic properties of an extremely rapid protein folding reaction. Biochemistry (1996) 1.45

Mechanism of folding of ribonuclease A. Slow refolding is a sequential reaction via structural intermediates. Biochemistry (1983) 1.45

Mustard's operation for transposition of the great arteries. Review of 200 cases. Lancet (1972) 1.43

Fetal cardiac catheterization using a percutaneous transhepatic access technique: preliminary experience in a lamb model. Ultrasound Obstet Gynecol (2013) 1.40

Thiopentone, thiopentone/ketamine, and ketamine for induction of anaesthesia in caesarean section. Eur J Anaesthesiol (1994) 1.39

Surgical closure of aorto-pulmonary window without cardiopulmonary bypass. Pediatr Cardiol (1989) 1.39

Transcatheter radiofrequency perforation and stent implantation for palliation of pulmonary atresia in a 3060-g infant. Cathet Cardiovasc Diagn (1995) 1.39

Kinetic coupling between protein folding and prolyl isomerization. I. Theoretical models. J Mol Biol (1992) 1.37

Quantification of regional intrapulmonary oxygen partial pressure evolution during apnea by (3)He MRI. J Magn Reson (1999) 1.34

A thermodynamic coupling mechanism for GroEL-mediated unfolding. Proc Natl Acad Sci U S A (1996) 1.31

Clinical and morphological characteristics in Streptococcus bovis endocarditis: a comparison with other causative microorganisms in 177 cases. Heart (1998) 1.27

Diffusional barrier crossing in a two-state protein folding reaction. Nat Struct Biol (1999) 1.25

Fabry disease: overall effects of agalsidase alfa treatment. Eur J Clin Invest (2004) 1.25

Stabilization of a protein by guanidinium chloride. Biochemistry (1993) 1.23

Complement C6 deficiency protects against diet-induced atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol (1998) 1.23

Replacement of a cis proline simplifies the mechanism of ribonuclease T1 folding. Biochemistry (1990) 1.23

Modular structure of the trigger factor required for high activity in protein folding. J Mol Biol (1997) 1.21

Distribution of the sensitivities to penicillin of types of Diplococcus pneumoniae in an American Indian population. J Infect Dis (1974) 1.20

Transcatheter closure of secundum atrial septal defects with the atrial septal defect occlusion system (ASDOS): initial experience in children. Heart (1996) 1.19

Stability, quaternary structure, and folding of internal, external, and core-glycosylated invertase from yeast. Protein Sci (1992) 1.18

Folding of ribonuclease T1. 1. Existence of multiple unfolded states created by proline isomerization. Biochemistry (1990) 1.18

The value of respiratory tract bacteriology in pneumococcal pneumonia among Navajo Indians. Am Rev Respir Dis (1974) 1.17

Folding of ribonuclease T1. 2. Kinetic models for the folding and unfolding reactions. Biochemistry (1990) 1.15

Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses. Eur J Pediatr (1995) 1.14

Electrostatic stabilization of a thermophilic cold shock protein. J Mol Biol (2001) 1.13

Decreases in unintegrated HIV DNA are associated with antiretroviral therapy in AIDS patients. J Acquir Immune Defic Syndr (1992) 1.13

Kinetic coupling between protein folding and prolyl isomerization. II. Folding of ribonuclease A and ribonuclease T1. J Mol Biol (1992) 1.12

Comparison of blood gases of ventilated patients during transport. Crit Care Med (1987) 1.12

Microsecond folding of the cold shock protein measured by a pressure-jump technique. Biochemistry (1999) 1.12

Dynamic association of trigger factor with protein substrates. J Mol Biol (2001) 1.11

Selecting proteins with improved stability by a phage-based method. Nat Biotechnol (1998) 1.10

Thermal stability and atomic-resolution crystal structure of the Bacillus caldolyticus cold shock protein. J Mol Biol (2000) 1.10

Protein folding as a diffusional process. Biochemistry (1999) 1.10

A native-like intermediate on the ribonuclease A folding pathway. 2. Comparison of its properties to native ribonuclease A. Eur J Biochem (1981) 1.09

Surgical treatment of myocardial bridging causing coronary artery obstruction. Scand J Thorac Cardiovasc Surg (1992) 1.08

[Experiences with nifedipine in the treatment of acute hypertension in childhood]. Monatsschr Kinderheilkd (1985) 1.07

Protein-disulphide isomerase and prolyl isomerase act differently and independently as catalysts of protein folding. Nature (1988) 1.07

In-vitro selection of highly stabilized protein variants with optimized surface. J Mol Biol (2001) 1.07

Role of proline peptide bond isomerization in unfolding and refolding of ribonuclease. Proc Natl Acad Sci U S A (1986) 1.06

Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury. J Pharmacol Exp Ther (1998) 1.06

Stenting of the ductus arteriosus and banding of the pulmonary arteries: basis for various surgical strategies in newborns with multiple left heart obstructive lesions. Heart (2003) 1.05

Assessment of a single-acquisition imaging sequence for oxygen-sensitive (3)He-MRI. Magn Reson Med (2002) 1.05

Enzyme replacement therapy in heterozygous females with Fabry disease: results of a phase IIIB study. J Inherit Metab Dis (2003) 1.04

(3)he-MRI-based measurements of intrapulmonary p(O2) and its time course during apnea in healthy volunteers: first results, reproducibility, and technical limitations. NMR Biomed (2000) 1.03

Detection of central pulmonary artery thromboemboli by transesophageal echocardiography in patients with severe pulmonary embolism. J Am Soc Echocardiogr (1992) 1.03

Folding mechanism of ribonuclease T1 in the absence of the disulfide bonds. Biochemistry (1994) 1.02

Complications of permanent transvenous cardiac pacing. J Thorac Cardiovasc Surg (1975) 1.01

Laryngeal mask airway position and the risk of gastric insufflation. Anesth Analg (1998) 1.01

Long-term results after thromboendarterectomy for chronic pulmonary embolism. Eur J Cardiothorac Surg (1999) 1.01

Combinations of the alpha-helix-turn-alpha-helix motif of TetR with respective residues from LacI or 434Cro: DNA recognition, inducer binding, and urea-dependent denaturation. Biochemistry (1997) 1.00

Fast-folding and slow-folding forms of unfolded proteins. Methods Enzymol (1986) 1.00

A native-like intermediate on the ribonuclease A folding pathway. 1. Detection by tyrosine fluorescence changes. Eur J Biochem (1981) 0.99

The mechanism of action of FK 506. Transplant Proc (1990) 0.99

Preferential binding of an unfolded protein to DsbA. EMBO J (1996) 0.99

Acetylcholine in isolated airways of rat, guinea pig, and human: species differences in role of airway mucosa. Am J Physiol (1996) 0.99

Folding of RNase T1 is decelerated by a specific tertiary contact in a folding intermediate. Proteins (1992) 0.99

Surface-exposed phenylalanines in the RNP1/RNP2 motif stabilize the cold-shock protein CspB from Bacillus subtilis. Proteins (1998) 0.99

Influence of mitral valve surgery on tricuspid incompetence concomitant with mitral valve disease. Circulation (1980) 0.98

The family of cold shock proteins of Bacillus subtilis. Stability and dynamics in vitro and in vivo. J Biol Chem (1999) 0.98

Cis proline mutants of ribonuclease A. II. Elimination of the slow-folding forms by mutation. Protein Sci (1992) 0.98

Continuous measurement of cardiac output by the Fick principle in infants and children: comparison with the thermodilution method. Intensive Care Med (1996) 0.97

Reassessment of the putative chaperone function of prolyl-cis/trans-isomerases. FEBS Lett (1994) 0.97

Expression of endothelial cell adhesion molecules on heart valves: up-regulation in degeneration as well as acute endocarditis. J Pathol (2000) 0.97

Cyclophilin and trigger factor from Bacillus subtilis catalyze in vitro protein folding and are necessary for viability under starvation conditions. Biochemistry (1998) 0.97

A kinetic analysis of the folding of human carbonic anhydrase II and its catalysis by cyclophilin. J Biol Chem (1995) 0.97

HIV-1 proviral copy number in blood mononuclear cells from AIDS patients on zidovudine therapy. J Acquir Immune Defic Syndr (1991) 0.96

Enzyme replacement therapy for mucopolysaccharidosis VI: long-term cardiac effects of galsulfase (Naglazyme®) therapy. J Inherit Metab Dis (2012) 0.95